Business · 02/09/2020Updated: 10/17/2026 · 1 min read
Janssen Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 16 New Drug Applications; Correction
Summary
The FDA is correcting a notice that withdrew the approval of 16 new drug applications, including Monodox capsules, after receiving a withdrawal request from Aqua Pharmaceuticals, LLC, due to a timely request to preserve the approval.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →